Dye-based liquid reagent volume indicator for use in analyte detection assays

Patent metadata

Field	Value
Publication number	US-11460476-B2
Application number	US-202017435433-A
Country	US
Kind code	B2
Filing date	Feb 26, 2020
Priority date	Mar 4, 2019
Publication date	Oct 4, 2022
Grant date	Oct 4, 2022

Abstract

Devices, kits, and methods are disclosed for use in detecting a concentration of an analyte of interest in a patient's liquid test sample. The devices, kits, and methods employ the use of one or more solid reagent zones that includes at least one analytical reagent for detection of an analyte of interest. The solid reagent zone(s) also includes at least one dye for determining whether results obtained from the diagnostic assay for the at least one analyte of interest are biased or inaccurate due to a loss of volume of a liquid reagent during the dispensing of the liquid reagent.

First claim

What is claimed is:

1. A method for detecting a concentration of an analyte of interest present within a patient's liquid test sample, the method comprising the steps of:
(A) providing a housing for conducting at least one diagnostic assay, wherein the housing comprises:
a reaction chamber for the conductance of one or more diagnostic assays, the reaction chamber further comprising at least one solid reagent zone, wherein the at least one solid reagent zone comprises:
at least one solid analytical reagent that specifically interacts or associates with the analyte of interest for detection of the analyte of interest; and
at least one solid dye, wherein the at least one dye produces at least two detectable responses when the at least one dye is mixed with at least one liquid reagent, wherein the at least two detectable responses produced by the at least one dye are measured at different wavelengths, and wherein the at least one dye does not interact or associate with the analyte of interest; and

a liquid analytical reagent dispensing apparatus contained within the housing, wherein the liquid analytical reagent dispensing apparatus contains at least one liquid analytical reagent and is in fluid communication with the reaction chamber to thereby dispense the at least one liquid analytical reagent into the reaction chamber at a predetermined time;

(B) introducing the liquid test sample into the reaction chamber;
(C) dispensing the at least one liquid analytical reagent from the dispensing apparatus into the reaction chamber, whereby the at least one liquid analytical reagent mixes with the liquid test sample and solubilizes the at least one solid analytical reagent and the at least one solid dye to thereby form a reaction mixture in the reaction chamber;
(D) performing an analytical assay procedure using the solubilized at least one analytical reagent to determine a concentration of the analyte of interest present in the liquid test sample;
(E) measuring a first detectable response in the reaction mixture for the at least one dye, wherein the first detectable response is measured at a first wavelength to obtain a first value;
(F) measuring a second detectable response in the reaction mixture for the at least one dye, wherein the second detectable response is measured at a second wavelength to obtain a second value;
(G) comparing the second value of (F) to an expected value to calculate buffer loss;
(H) comparing the first and second values to determine if any interference contribution of the at least one dye is present in the concentration of the analyte of interest determined in step (D); and
(I) calculating a corrected concentration of the analyte of interest present in the liquid test sample using the comparisons of steps (G) and (H) to thereby remove any interference contribution of the at least one dye and to correct for any inaccuracy or bias caused by loss of volume of the at least one liquid analytical reagent during the dispensing step.

2. The method of claim 1 , wherein the liquid test sample is a volume of whole blood.

3. The method of claim 2 , wherein the volume of whole blood is in a range of from about 0.1 microliter to about 100 microliters.

4. The method of claim 1 , wherein the at least one solid reagent zone further comprises at least one oxidant.

5. The method of claim 4 , wherein the at least one oxidant comprises ferricyanide.

6. The method of claim 1 , wherein the at least one dye is selected from the group consisting of naphthol green B (NGB), 1,1′,3,3,3′,3′-hexamethyllindotricarbocyanine iodide, 1,1′-diethyl-4,4′-carbocyanine iodide, manganese (II) pthalocyanine, silicon 2,3-napthalocyanine dichloride, 3,3′-diethylthiatricarbocyanine perchlorate, near infrared (NIR)-II dye carboxylic functionalized, and combinations thereof.

7. The method of claim 1 , wherein the at least one liquid analytical reagent comprises at least one buffer having a volume of about 600 microliters.

8. The method of claim 1 , wherein the first wavelength is about 536 nanometers.

9. The method of claim 1 , wherein the second wavelength is about 725 nanometers.

10. The method of claim 1 , wherein the analyte of interest is selected from the group consisting of total hemoglobin, glycated hemoglobin, and combinations thereof.

11. An improved analytical reaction kit for use in the conductance of at least one diagnostic assay on a patient's liquid test sample, comprising:
a housing for conducting at least one diagnostic assay, wherein the housing comprises a reaction chamber for the conductance of one or more diagnostic assays, the reaction chamber further comprising at least one solid reagent zone, wherein the at least one solid reagent zone comprises:
at least one solid analytical reagent that specifically interacts or associates with the analyte of interest for detection of the analyte of interest; and
at least one solid dye, wherein the at least one dye produces at least two detectable responses when the at least one dye is mixed with at least one liquid reagent, wherein the at least two detectable responses produced by the at least one dye are measured at different wavelengths, and wherein the at least one dye does not interact or associate with the analyte of interest; and

a liquid analytical reagent dispensing apparatus contained within the housing, wherein the liquid analytical reagent dispensing apparatus contains at least one liquid analytical reagent and is in fluid communication with the reaction chamber to thereby dispense the at least one liquid analytical reagent into the reaction chamber at a predetermined time.

12. The analytical reaction kit of claim 11 , wherein the liquid test sample is a volume of whole blood.

13. The analytical reaction kit of claim 12 , wherein the volume of whole blood is in a range of from about 0.1 microliter to about 100 microliters.

14. The analytical reaction kit of claim 11 , wherein the at least one solid reagent zone further comprises at least one oxidant.

15. The analytical reaction kit of claim 14 , wherein the at least one oxidant comprises ferricyanide.

16. The analytical reaction kit of claim 11 , wherein the at least one dye comprises a known absorbance in a spectral range of from about 700 nanometers to about 900 nanometers.

17. The analytical reaction kit of claim 16 , wherein the at least one dye is selected from the group consisting of naphthol green B (NGB), 1,1′,3,3,3′,3′-hexamethyllindotricarbocyanine iodide, 1,1′-diethyl-4,4′-carbocyanine iodide, manganese (II) pthalocyanine, silicon 2,3-napthalocyanine dichloride, 3,3′-diethylthiatricarbocyanine perchlorate, near infrared (NIR)-II dye carboxylic functionalized, and combinations thereof.

18. The analytical reaction kit of claim 11 , wherein the at least one diagnostic assay comprises a glycated hemoglobin detection assay.

19. The analytical reaction kit of claim 11 , wherein the at least one liquid analytical reagent comprises at least one buffer comprising a volume of about 600 microliters.

20. The analytical reaction kit of claim 11 , wherein the reaction chamber of the housing further comprises a sample read window.

Assignees

• Siemens Healthcare Diagnostics Inc

Inventors

• Kauffmann Aaron
• Ledden David
• Zimmerle Chris
• Stradinger Jon

Classifications

• B01L2300/044

  pierceable, e.g. films, membranes · CPC title

• B01L3/502 Primary

  with fluid transport, e.g. in multi-compartment structures · CPC title

• B01L2200/148

  Specific details about calibrations · CPC title

• B01L3/527

  for a plurality of reagents · CPC title

• G01N2440/38

  addition of carbohydrates, e.g. glycosylation, glycation · CPC title